DEA insists cold drug is not meth-resistant

by Jim Salter

A cold and allergy decongestant containing what the manufacturer says is the first pseudoephedrine that cannot be used in meth production is now available nationwide.

The Drug Enforcement Administration refuses to allow Zephrex-D to be sold over the counter, saying government chemists were able to manufacture from the product.

Zephrex-D has been sold in Missouri since December and suburban St. Louis company Westport Pharmaceuticals rolled out the product to 15,000 pharmacies nationwide last month.

Westport says the amount of meth that can be made using Zephrex-D is so small that it's impractical for meth-makers. The Missouri Narcotics Officers Association says it hasn't found the product in any meth labs.

Nonetheless, the DEA insisted Tuesday that Zephrex-D must be sold from behind the counter like all other products.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

DEA disagrees with firm's meth-resistant claims

May 29, 2013

The Drug Enforcement Administration says a suburban St. Louis pharmaceutical company is wrong for marketing its pseudoephedrine product to imply methamphetamine cannot be made with it.

DEA demonstrates how to make meth

May 29, 2007

The Drug Enforcement Administration a held methamphetamine making seminar in Denver to demonstrate what its agents keep off the streets.

Recommended for you

Health care M&A leads global deal surge

8 hours ago

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.